Meeting NewsVideo

VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD

CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy of Ophthalmology meeting here.

CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy of Ophthalmology meeting here.

    See more from American Academy of Ophthalmology Meeting